Purpose: To synthesise, charecterise phenyl hydrazones namely, {4-[3-methyl-5-oxo-4-(phenyl hydrazono)-4,5-dihydro-pyrazol-1-yl]-phenoxy}-acetic acid N | -(4-substitutedthiazole-2-yl)-hydrazide VII and to evaluate the antibacrial activity.
INTRODUCTION
Inspite of many significant advances in antibacterial therapy, infectious diseases caused by bacteria and microbes have increased dramatically in recent years. This is due to the increased resistance of disease causing microbes to antibiotic drug therapy. The antibiotic prescription, whether appropriate or inappropriate, can contribute to the surfacing of antibiotic resistant bacteria. In case of appropriate priscriptions, the disadvantage of emergence of antibiotic resistant bacteria is offset by the necessity for the treatment of the concerned bacterial infection. The inappropriate priscriptions do not lead to any kind of benefit to the patient but only increase the spread of resistant bacteria. However in both the cases, use of antibiotics is directly related to the spread of antibiotic resistant bacteria (Ballow and Schentag, 1992 , McGowan, 1983 , Mouton et al., 1990 Ringertz and Kronvall 1987 . On the other hand this scenario has neccissiated the development of new drugs to deal with resistant bacteria.
Nitrogen and sulfur heterocyclic systems have gained great deal of importance because of their diverse pharmacological properties and hense are extensively integrated into new drugs. Particularly compounds containing the pyrzoline ring system and thiazole ring system are known to possess potent therapeutic properties (Andreani et al., 1996 , Kucukguzel et al., 2006 , Pattan et al., 2006 , Pushkal et al., 2012 , Prem et al., 1977 , Narayana et al., 2006 , Tapia et al., 2003 , Verma and Saraf 2008 . Keeping these details and the need for the development of new drugs in view, we herein report a new series of compounds containing these multiactive nuclei to ensure wide spectrum of antimicrobial activity.
EXPERIMENTAL

Instuments and Chemicals
IR spectra were recorded on a Perkin-Elmer 983 IR spectrometer.
1 H NMR spectra were recorded on a Bruker AC 300F (200 MHz) NMR spectrometer using DMSO -d 6 as a solvent and TMS as an internal standard. Mass spectra of the compounds were recorded on a Jeol JMS-D300 mass spectrometer operating at 70 eV.
Nutrient broth, nutrient agar and 5 mm diameter antibiotic assay discs were obtained from Hi-Media Laboratories Limited, India. All the reagents and chemicals used were of analytical reagent grade procured from Ranbaxy Laboratories Ltd, India. The standard bacterial and fungal strains were procured from National Centre for Cell Science, Pune, India.
Synthesis of title compounds
The substituted aryl bromides were sysnthesysed by the procedure mentioned in the literature 13 .
Synthesis of {4-[3-Methyl-5-oxo-4-(phenyl hydrazono)-4,5-dihydro-pyrazol-1-yl]-phenoxy}-acetic acid ethyl ester (V)
Phenyl diazonium acetoacetic ester (II) was prepared by the procuedure mentioned in the literature (Dastagiri Reddy et al., 2013) 13 .
Phenyl hydrazono aceto acetic ester (II) and hydrazine in the presence of dimethyl formamide (10 drops) under microwave irradiation at 150W intermittently at 30 sec intervals for 2 minutes resulted in the formation of 4-[3-Methyl-4-(phenyl hydrazono)-pyrazoline-3-one III. 
Synthesis of {4-[3-methyl-5-oxo-4-(phenyl hydrazono)-4,5-dihydro-pyrazol-1-yl]-phenoxy}-aceto thiosemicarbazone VI.
A mixture of {4-[3-Methyl-5-oxo-4--(phenyl hydrazono)-4,5-dihydro-pyrazol-1-yl]-phenoxy}-acetic acid hydrazide V (0.01 mole), potassium thiocyanate (0.02 mole), concentrated hydrochloric acid (1 mL), ethyl alcohol (10 mL) and water (20 mL) were refluxed for 3 hours. The solution was cooled, filtered, the precipitate was washed with water, dried and recrystallized from ethanol-DMF mixture to yield 3-methyl-5-oxo-4(phenylhydrazono)4,5-dihydropyrazol-1-ylacetothiosemicarbazone VI.
A mixture of {4-[3-methyl-5-oxo-4(phenyl hydrazono)-4,5-dihydro pyrazol-1-yl]-phenoxyamino}-aceto thiosemicarbazone VI (0.01 mole) in dimethylformamide (10 mL) and bromo acetophenone (0.01 mol) in ethanol (10mL) was stirred at room temperature for 2 hours. The solid seperted was filtered, dried, recrystallized from ethanol-DMF mixture and found to be {4-
The detailed steps leading to the formation of title compounds is given in Scheme 1.
The above reaction was extended to different bromo acetyl derivatives i.e. p-tolyl, p- Pharmacy (ISSN 19204159) ; www.japharmacy.ca
RESULTS AND DISCUSSION
{4-[3-Methyl-5-oxo-4--(phenyl hydrazono)-4,5-dihydro-pyrazol-1-yl]-phenoxy}
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Antimicrobial activity
The antimicrobial activity of title compounds was studied by disc diffusion method (Ericsson and Sherris, 1971) 14 against certain pathogenic organisms. The antibacterial activity of synthesized compounds (250 μg/mL using DMSO as a solvent) was studied against gram positive bacteria namely Staphylococcus aureus NCCS 2079 and Bacillus cereus NCCS 2106. The gram negative bacterial screened were Escherichia coli NCCS 265 and Pseudomonas aeruginosa NCCS 2200. Amoxicillin 10 μg/mL and cefaclor 30 μg/mL were used as a standard for assessing the antibacterial studies. The antifungal activity of synthesized compounds (100 μg/mL using DMSO as a solvent) was studied against Aspergillus niger NCCS 1196 and Candida albicans NCCS 3471. Ketaconazole 50 μg/mL was used as a standard for assessing the antifungal studies.
It can be seen from the Table 1that , VIIe, f and g with substituents namely p-nitrophenyl, p-chlorophenyl, p-bromophenyl were more active agaist bacteria, where as the compounds VIIa, b, c, d and e with substituents namely phenyl, p-tolyl, p-anisyl, p-hydroxyphenyl, pnitrophenyl were more active against fungi than the other compounds under study. The compound VIIe with p-nitrophenyl substituent was found to exhibit significant activity against both bacteria and fungi.
